---
document_datetime: 2025-11-10 10:35:54
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/rezdiffra-epar-all-authorised-presentations_en.pdf
document_name: rezdiffra-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.4437204
conversion_datetime: 2025-12-25 06:50:48.836119
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Annex A

<div style=\"page-break-after: always\"></div>

## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Pack size

EU/1/25/1962/001 Rezdiffra 60 mg Film-coated tablet Oral use blister (PVC/PCTFE/alu) 28 tablets EU/1/25/1962/002 Rezdiffra 80 mg Film-coated tablet Oral use blister (PVC/PCTFE/alu) 28 tablets EU/1/25/1962/003 Rezdiffra 100 mg Film-coated tablet Oral use blister (PVC/PCTFE/alu) 28 tablets